Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Post-Discharge Thromboembolic Events in Covid-19 Patients: A Review on the Necessity for Prophylaxis Publisher Pubmed



Mehrabi F1 ; Farshbafnadi M2 ; Rezaei N3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Universal Scientific Education and Research Network (USERN), Tehran, Iran
  2. 2. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Center for Immunodeficiencies, Children's Medical Center Hospital, Tehran University of Medical Sciences, Tehran, Iran

Source: Clinical and Applied Thrombosis/Hemostasis Published:2023


Abstract

Coronavirus disease 2019 (COVID-19) affects the respiratory system of patients and is characterized by pneumonia with hypoxemia. Hospitalized patients and particularly those admitted to intensive care unit (ICU) may encounter a cascade of coagulopathies, which may lead to macrovessel thrombotic events such as pulmonary embolism (PE), deep vein thrombosis (DVT), or arterial thromboembolism (ATE). These events can result in serious life-threatening diseases including cerebrovascular stroke and myocardial infarction. Despite all available information about the incidence, prevention, and treatment of venous thromboembolism (VTE) among hospitalized patients, few data are available on the incidence of both symptomatic and subclinical VTE after discharge. Therefore, there is no precise suggestion or guideline for prophylaxis against VTE in post-discharge period, and some controversies exist over the current guidelines. In the present study, we aimed to review and summarize available literature upon incidence, prevention, diagnosis, and therapeutic approaches for VTE in COVID-19 patients. Also, the pathogenic mechanisms of VTE in infected individuals with COVID-19 were discussed. © The Author(s) 2023.
Related Docs
View other Related Docs
1. Coagulopathy and Thromboembolic Events a Pathogenic Mechanism of Covid-19 Associated With Mortality: An Updated Review, Journal of Clinical Laboratory Analysis (2023)
2. Covid-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment, Seminars in Thrombosis and Hemostasis (2023)
3. Cardiovascular Diseases Burden in Covid-19: Systematic Review and Meta-Analysis, American Journal of Emergency Medicine (2021)
4. Coagulopathy: Another Side Effect of Coronavirus Infection, Journal of Cardiovascular and Thoracic Research (2021)
5. Venous Thromboembolism in Viral Diseases: A Comprehensive Literature Review, Health Science Reports (2023)
6. Anticoagulant Therapy in Covid-19: A Narrative Review, Clinical and Translational Science (2023)
7. Recent Randomized Trials of Antithrombotic Therapy for Patients With Covid-19: Jacc State-Of-The-Art Review, Journal of the American College of Cardiology (2021)
8. Thrombotic Storm in Coronavirus Disease 2019: From Underlying Mechanisms to Its Management, Journal of Medical Microbiology (2022)
Experts (# of related papers)
View all Related Experts
Azita Hajhossein Talasaz (13)
Hossein Khalili (9)
Other Related Docs
9. Effect of Intermediate-Dose Vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With Covid-19 Admitted to the Intensive Care Unit: The Inspiration Randomized Clinical Trial, JAMA - Journal of the American Medical Association (2021)
10. Sars-Cov-2-Related and Covid-19 Vaccine-Induced Thromboembolic Events: A Comparative Review, Reviews in Medical Virology (2022)
11. Intermediate Versus Standard-Dose Prophylactic Anticoagulation and Statin Therapy Versus Placebo in Critically-Ill Patients With Covid-19: Rationale and Design of the Inspiration/Inspiration-S Studies, Thrombosis Research (2020)
12. Ischemic Gastrointestinal Complications of Covid-19: A Systematic Review on Imaging Presentation, Clinical Imaging (2021)
13. Covid-19 Infection and Stroke Risk, Reviews in the Neurosciences (2021)
14. Comprehensive Review of Cardiovascular Complications of Coronavirus Disease 2019 and Beneficial Treatments, Cardiology in Review (2022)
15. Pathogenesis, Clinical Manifestations and Complications of Coronavirus Disease 2019 (Covid-19), Future Microbiology (2020)
16. Dysregulated Mirnas Network in the Critical Covid-19: An Important Clue for Uncontrolled Immunothrombosis/Thromboinflammation, International Immunopharmacology (2022)
17. Corona Virus Disease 2019 (Covid-19) As a System-Level Infectious Disease With Distinct Sex Disparities, Frontiers in Immunology (2021)
18. Pharmacotherapy for Prevention and Management of Thrombosis in Covid-19, Seminars in Thrombosis and Hemostasis (2020)
19. Pharmacotherapy Consideration of Thrombolytic Medications in Covid-19-Associated Ards, Journal of Intensive Care (2022)
20. The Evaluation of Hematological Parameters and Their Correlation With Disease Prognosis in Covid-19 Disease in Iran, International Journal of Hematology-Oncology and Stem Cell Research (2023)
21. Covid-19 and Cardiovascular Diseases, Advances in Experimental Medicine and Biology (2021)
22. Cardiovascular Complications of Covid-19: Pharmacotherapy Perspective, Cardiovascular Drugs and Therapy (2021)
23. Diabetes As One of the Long-Term Covid-19 Complications: From the Potential Reason of More Diabetic Patients’ Susceptibility to Covid-19 to the Possible Caution of Future Global Diabetes Tsunami, Inflammopharmacology (2023)
24. Obesity in Covid-19 Era, Implications for Mechanisms, Comorbidities, and Prognosis: A Review and Meta-Analysis, International Journal of Obesity (2021)
25. Biomarker Based Biosensors: An Opportunity for Diagnosis of Covid-19, Reviews in Medical Virology (2022)
26. Cardiovascular Disease in Covid-19: A Systematic Review and Meta-Analysis of 10,898 Patients and Proposal of a Triage Risk Stratification Tool, Egyptian Heart Journal (2020)
27. Pathological Effects of Sars-Cov-2 on Hematological and Immunological Cells: Alterations in Count, Morphology, and Function, Pathology Research and Practice (2022)
28. Immunopathological Similarities Between Covid-19 and Influenza: Investigating the Consequences of Co-Infection, Microbial Pathogenesis (2021)
29. Immunosenescence and Inflamm-Ageing in Covid-19, Ageing Research Reviews (2023)
30. Intermediate-Dose Versus Standard-Dose Prophylactic Anticoagulation in Patients With Covid-19 Admitted to the Intensive Care Unit: 90-Day Results From the Inspiration Randomized Trial, Thrombosis and Haemostasis (2021)
31. Cardiovascular Implications of the Covid-19: Management of Complications and Drug Safety Concerns, Journal of Research in Medical Sciences (2022)
32. The Use of Mesenchymal Stem Cells in the Process of Treatment and Tissue Regeneration After Recovery in Patients With Covid-19, Gene (2021)
33. Covid-19 and Multiorgan Failure: A Narrative Review on Potential Mechanisms, Journal of Molecular Histology (2020)
34. Covid-19: Review of a 21St Century Pandemic From Etiology to Neuro-Psychiatric Implications, Journal of Alzheimer's Disease (2020)
35. Knowledge Gaps for Prophylactic Use of Antithrombotic Agents in Patients With Covid-19: Insights Into New Sars-Cov-2 Variants, Vaccination Status, and Emerging Oral Antivirals, Thrombosis and Haemostasis (2023)
36. Giant Intracardiac Thrombosis in an Infant With Leukaemia and Prolonged Covid-19 Viral Rna Shedding: A Case Report, Thrombosis Journal (2021)
37. Remdesivir: A Beacon of Hope From Ebola Virus Disease to Covid-19, Reviews in Medical Virology (2020)
38. Risk of Stroke in Hospitalized Sars-Cov-2 Infected Patients: A Multinational Study, EBioMedicine (2020)
39. Covid-19 and Congenital Heart Disease: A Case Series of Nine Children, World Journal of Pediatrics (2021)
40. Early Percutaneous Dilational Tracheostomy in Covid-19 Patients: A Case Report, Clinical Case Reports (2021)
41. A Review on Headaches Due to Covid-19 Infection, Frontiers in Neurology (2022)
42. Acute Upper Limb Ischemia in a Patient With Covid-19: A Case Report, Annals of Vascular Surgery (2021)
43. Molecular Signaling Pathways, Pathophysiological Features in Various Organs, and Treatment Strategies in Sars-Cov2 Infection, Acta Histochemica (2022)
44. Covid-19 Associated Thrombotic Thrombocytopenic Purpura (Ttp); a Case Series and Mini-Review, International Immunopharmacology (2021)
45. Late Complications of Covid-19; a Systematic Review of Current Evidence, Archives of Academic Emergency Medicine (2020)
46. Covid-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods, Anti-Cancer Agents in Medicinal Chemistry (2021)
47. Potential of Therapeutic Plasmapheresis in Treatment of Covid-19 Patients: Immunopathogenesis and Coagulopathy, Transfusion and Apheresis Science (2020)
48. The Relationship of Covid-19 Severity With Laboratory Findings and Neutrophil-To-Lymphocyte Ratio in Patients Admitted to a Large Teaching Hospital in Iran: A Cross-Sectional Study, Health Science Reports (2024)
49. Management of St-Segment-Elevation Myocardial Infarction During the Coronavirus Disease 2019 (Covid-19) Outbreak: Iranian“247” National Committee's Position Paper on Primary Percutaneous Coronary Intervention, Catheterization and Cardiovascular Interventions (2021)
50. Relationship Between Comorbidity, Chronic Diseases, Icu Hospitalization, and Death Rate in the Elderly With Coronavirus Infection, Iranian Journal of Ageing (2021)